Technology
New On Robinhood
Health
NextCure
$26.569876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$26.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.81 (3.15%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours
Why Robinhood?
You can buy or sell NextCure and other stocks, options, ETFs, and crypto commission-free!
About NXTC
NextCure, Inc. Common Stock, also called NextCure, is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Read More Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.
Employees
44
Headquarters
Beltsville, Maryland
Founded
2015
Market Cap
603.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
78.62K
High Today
$27.50
Low Today
$25.89
Open Price
$25.89
Volume
41.19K
52 Week High
$28.00
52 Week Low
$13.86
Collections
Technology
New On Robinhood
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical
NXTC Earnings
-$5.35
-$4.76
-$4.16
-$3.57
Q1 2019
Q2 2019
Estimated
—
Actual
Available Aug 12, After Hours